4//SEC Filing
Sullivan Eric 4
Accession 0000899243-22-039023
CIK 0001750019other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:29 PM ET
Size
7.9 KB
Accession
0000899243-22-039023
Insider Transaction Report
Form 4
Sullivan Eric
Chief Financial Officer
Transactions
- Award
Restricted Stock Unit (Right to Buy)
2022-12-15+6,804→ 6,804 total→ Common Stock (6,804 underlying) - Award
Stock Option (Right to Buy)
2022-12-15+40,820→ 40,820 totalExercise: $0.97Exp: 2032-12-14→ Common Stock (40,820 underlying)
Footnotes (3)
- [F1]25% of this option shall vest and become exercisable on the one-year anniversary of the date of grant, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
- [F3]The restricted stock units will vest 25% on the one-year anniversary of the date of grant, with the remainder vesting in three equal annual installments thereafter.
Documents
Issuer
TCR2 THERAPEUTICS INC.
CIK 0001750019
Entity typeother
Related Parties
1- filerCIK 0001601797
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:29 PM ET
- Size
- 7.9 KB